Nivedita ‘Niv’ Hegdekar is a graduate student at the University of Maryland, Baltimore pursuing a dual degree in biomedical sciences and patent law. Prior to joining her PhD program, she obtained her degree in pharmacy and pharmaceutical sciences from the prestigious Institute of Chemical Technology, Mumbai, India.
Natalie McKinney is a marketing strategy leader with 15+ years of experience in life sciences and technology organizations. She uses data-driven, customer-centric approaches to gain a deep understanding of dynamic customer needs and drivers. She enjoys leveraging internal and external relationships to build a holistic customer view and gains alignment on high-impact, right-sized product and marketing investments that are timed appropriately for the market.
In the heart of pharmaceutical and medical innovation lies an undiscovered treasure that provides a pathway for med-tech innovation, the Maryland Development Council (MDC). The council is a MedTech Startup Studio that works with inventors to develop their ideas into working prototypes and marketable products.
The University of Maryland, Baltimore (UMB) is the state’s public health, law, and human services university devoted to excellence in professional and graduate education, research, patient care, and public service.
Brian Darmody is CEO of AURP, a global nonprofit representing research parks and innovation districts sponsored by universities, federal labs, communities, hospitals, and other institutions in the US and 12 other countries.
For decades, the United States and the United Kingdom have enjoyed a special relationship that crosses political, economic, and military lines. But, the two nations also share a similar comradery in the Life Sciences arena, and prominent biotech hubs like the BioHealth Capital Region and Philadelphia showcase that connection.
UM School of Medicine and School of Pharmacy Researchers Identify Promising New Compounds to Potentially Treat Novel Coronaviruses | University of Maryland School of MedicinePublished on :
Researchers at the University of Maryland School of Medicine (UMSOM) and School of Pharmacy (UMSOP) have discovered new drug compounds to potentially treat the novel coronavirus that causes COVID-19. The [….]
Over the past nine months, more than $7 billion in federal funding has poured into the BioHealth Capital Region aimed at the battle against COVID-19 and has shown a spotlight on the broad impact biopharma life science companies and academic institutions are making in the fight against the pandemic.
New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients Original Story: University of Maryland School of Medicine News October 22, [….]
The state of Maryland is the global epicenter of vaccine research and development. This has never been more evident than right now as scores of Maryland companies have risen to the global challenge of developing the first approved vaccine for SARS-CoV-2.